- CRS Publications
- News
News
Authors:
Date:
Business Wire: May 26, 2016 – DUBLIN, OH, U.S.A. – Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announced the receipt of an initial notice of award for a fast-track Small Business Innovation Research (SBIR) grant providing for up to $1.8 million from the National Institutes of Health’s (NIH’s…
Authors:
Date:
Business Wire: May 16, 2016 – STOCKHOLM, Sweden – Nanologica entered into a license and collaboration agreement with Alcyone Lifesciences to develop Abela, a treatment for motor neuron disorders including ALS.
Nanologica today announced that it has entered into a License and Collaboration Agreement…
Authors:
Date:
Business Wire: May 12, 2016 – PARIS, France, and STANS, Switzerland – NLS Pharma Group announced the submission of an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a phase IIb clinical trial with its lead compound Mazindol. The study is…
Authors:
Date:
Business Wire: August 15, 2016 – LOUGHBOROUGH, England – Nemaura Pharma has been awarded the prestigious 2016 Frost & Sullivan award for best practices in enabling technology leadership in the transdermal drug delivery industry.
The analysts stated that “Nemaura Pharma’s drug delivery…
Authors:
Date:
This first wave of computational modeling in pharmaceutical science was the application of informatics-based methods to finding optimum drug molecule structures: drug design. We can now move beyond this, both from drug design to the design of drug delivery vehicles, nanomedicine, and from raw…
Authors:
IntroductionNowadays, most of the currently available ocular drugs are administered topically through eye drops,1 but their residence time in the eye is short, about 2 min…
